By Rob Polansky A multifaceted bill that encourages equitable gender and racial government representation, as well as helps parents running for office, has been signed into law. Gov. Ned Lamont signed the legislation on Tuesday. First, the bill promotes greater gender and racial diversity of appointments on state boards and commissions. It creates a statutory
More
By Gregory Krieg, Ethan Cohen and Adam Levy The campaign to become New York City’s next mayor has come in for another twist. On Tuesday, the City Board of Elections released new numbers that suggested Brooklyn Borough President Eric Adams’ lead in the Democratic primary had narrowed in the first set of tabulated ranked-choice voting results. Former
More
By Phil Mattingly President Joe Biden announced eight new federal judicial nominations on Wednesday as the White House seeks to maintain its rapid pace of nominations — and confirmations — to the federal bench. The announcement, which marked Biden’s fifth wave of judicial nominees, includes his intent to nominate two circuit court selections and comes as Democrats are pressing
More
by Seamus Fagan Seven-time Wimbledon champion Serena Williams was forced to retire from her first-round match at the All England Club against Aliaksandra Sasnovich on Tuesday due to an injury suffered in the first set. With Williams leading 3-1 in the first set, the 39-year-old American appeared to slip and hurt herself during a return. Williams
More
By Devan Cole Agriculture Secretary Tom Vilsack will appoint Randy Moore as the new chief of the US Forest Service, making him the first African American to lead the agency once sworn in, Vilsack announced Monday. Moore, a longtime employee of the Forest Service, will take the agency’s reins just as it braces for the 2021
More
By Jacqueline Howard Two House committees have launched an investigation into the approval and pricing of the Alzheimer’s disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm. The US Food and Drug Administration approved the drug earlier this month under its “accelerated approval” program, although an FDA advisory committee concluded last
More